Patrick Joseph Loehrer Sr.: Clinical Trials

5 trials sponsored by Patrick Joseph Loehrer Sr., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 withdrawn. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1
Phase 11Terminated 1

Follow Patrick Joseph Loehrer Sr.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)
Lonsurf, Gemcitabine, Nab-Paclitaxel - Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma
Phase 1TerminatedPatrick Joseph Loehrer Sr.142019-09-112024-01-05
Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma
Cabozantinib 40 MG, Erlotinib 100Mg Tab - Pancreatic Adenocarcinoma Metastatic
Phase 2TerminatedPatrick Joseph Loehrer Sr.72017-10-132020-08-27
A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas
BKM120 - Thymoma
Phase 2CompletedPatrick Joseph Loehrer Sr.142014-10-012022-04-11
Feasibility of Biodynamic Imaging for Predicting Therapeutic Effect in Metastatic Adenocarcinoma of the Pancreas
Metastatic Pancreatic Cancer
WithdrawnPatrick Joseph Loehrer Sr.2014-07-012019-07-10
Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma
Premetrexed (Alimta) - Thymoma, Thymic Carcinoma
Phase 2CompletedPatrick Joseph Loehrer Sr.272005-01-012019-07-22

Conditions studied

Pancreatic Neoplasms (2)  ·  Thymoma (2)

Interventions

130-nm albumin-bound paclitaxel (1)  ·  Erlotinib Hydrochloride (1)  ·  Gemcitabine (1)  ·  NVP-BKM120 (1)  ·  Pemetrexed (1)  ·  cabozantinib (1)  ·  trifluridine tipiracil drug combination (1)

Countries

United States (4)

Top investigators

Patrick Loehrer, M.D. (2)  ·  Bert H. O'Neil, MD (1)  ·  Bert O'Neil, MD (1)  ·  Patrick J Loehrer, MD (1)

Results publications

PMID 26766736, PMID 36330484